ProShare Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.19M | Buy |
37,088
+6,437
| +21% | +$564K | ﹤0.01% | 632 |
|
|
2026
Q1 | $2.77M | Sell |
30,651
-7,630
| -20% | -$700K | ﹤0.01% | 655 |
|
|
2025
Q4 | $3.44M | Buy |
38,281
+3,077
| +9% | +$292K | 0.01% | 629 |
|
|
2025
Q3 | $3.47M | Sell |
35,204
-46
| -0.1% | -$4.56K | 0.01% | 623 |
|
|
2025
Q2 | $3.22M | Buy |
35,250
+3,691
| +12% | +$357K | 0.01% | 627 |
|
|
2025
Q1 | $3.57M | Buy |
31,559
+1,422
| +5% | +$152K | 0.01% | 579 |
|
|
2024
Q4 | $3.18M | Sell |
30,137
-24,819
| -45% | -$2.66M | 0.01% | 599 |
|
|
2024
Q3 | $5.93M | Buy |
54,956
+25,029
| +84% | +$2.73M | 0.01% | 484 |
|
|
2024
Q2 | $3.25M | Buy |
29,927
+1,722
| +6% | +$203K | 0.01% | 586 |
|
|
2024
Q1 | $3.72M | Sell |
28,205
-725
| -3% | -$90.6K | 0.01% | 548 |
|
|
2023
Q4 | $3.52M | Sell |
28,930
-2,875
| -9% | -$321K | 0.01% | 548 |
|
|
2023
Q3 | $3.57M | Sell |
31,805
-1,336
| -4% | -$170K | 0.01% | 538 |
|
|
2023
Q2 | $4.83M | Buy |
33,141
+681
| +2% | +$92.5K | 0.01% | 504 |
|
|
2023
Q1 | $4.19M | Buy |
32,460
+4,051
| +14% | +$509K | 0.01% | 513 |
|
|
2022
Q4 | $3.62M | Sell |
28,409
-152
| -0.5% | -$17.6K | 0.01% | 507 |
|
|
2022
Q3 | $2.99M | Sell |
28,561
-3,205
| -10% | -$352K | 0.01% | 537 |
|
|
2022
Q2 | $3.34M | Sell |
31,766
-12,385
| -28% | -$1.47M | 0.01% | 561 |
|
|
2022
Q1 | $5.65M | Sell |
44,151
-2,629
| -6% | -$317K | 0.01% | 526 |
|
|
2021
Q4 | $5.77M | Buy |
46,780
+10,543
| +29% | +$1.38M | 0.01% | 533 |
|
|
2021
Q3 | $5.15M | Sell |
36,237
-833
| -2% | -$123K | 0.01% | 513 |
|
|
2021
Q2 | $5.79M | Buy |
37,070
+6,163
| +20% | +$998K | 0.02% | 480 |
|
|
2021
Q1 | $4.8M | Buy |
30,907
+1,591
| +5% | +$246K | 0.02% | 474 |
|
|
2020
Q4 | $4.39M | Buy |
29,316
+2,949
| +11% | +$417K | 0.02% | 456 |
|
|
2020
Q3 | $3.48M | Buy |
26,367
+816
| +3% | +$107K | 0.02% | 456 |
|
|
2020
Q2 | $2.96M | Buy |
25,551
+3,533
| +16% | +$407K | 0.02% | 481 |
|
|
2020
Q1 | $2.16M | Sell |
22,018
-15,218
| -41% | -$1.99M | 0.02% | 477 |
|
|
2019
Q4 | $5.41M | Buy |
37,236
+7,695
| +26% | +$1.06M | 0.03% | 441 |
|
|
2019
Q3 | $3.94M | Buy |
29,541
+1,882
| +7% | +$243K | 0.02% | 462 |
|
|
2019
Q2 | $3.16M | Sell |
27,659
-5,280
| -16% | -$618K | 0.02% | 496 |
|
|
2019
Q1 | $4.08M | Sell |
32,939
-5,355
| -14% | -$609K | 0.02% | 455 |
|
|
2018
Q4 | $3.86M | Buy |
38,294
+8,972
| +31% | +$1.01M | 0.03% | 439 |
|
|
2018
Q3 | $3.74M | Sell |
29,322
-2,640
| -8% | -$314K | 0.03% | 489 |
|
|
2018
Q2 | $3.46M | Sell |
31,962
-2,313
| -7% | -$252K | 0.02% | 515 |
|
|
2018
Q1 | $3.63M | Buy |
34,275
+969
| +3% | +$113K | 0.02% | 505 |
|
|
2017
Q4 | $3.9M | Buy |
33,306
+9,735
| +41% | +$1.1M | 0.03% | 477 |
|
|
2017
Q3 | $2.68M | Buy |
23,571
+3,411
| +17% | +$394K | 0.02% | 504 |
|
|
2017
Q2 | $2.51M | Sell |
20,160
-654
| -3% | -$77.5K | 0.03% | 506 |
|
|
2017
Q1 | $2.47M | Sell |
20,814
-3,549
| -15% | -$402K | 0.03% | 499 |
|
|
2016
Q4 | $2.44M | Buy |
24,363
+7,894
| +48% | +$846K | 0.03% | 492 |
|
|
2016
Q3 | $2.08M | Sell |
16,469
-8,325
| -34% | -$1.03M | 0.03% | 478 |
|
|
2016
Q2 | $2.9M | Buy |
24,794
+2,921
| +13% | +$331K | 0.04% | 368 |
|
|
2016
Q1 | $2.26M | Sell |
21,873
-9,131
| -29% | -$883K | 0.03% | 421 |
|
|
2015
Q4 | $3.09M | Buy |
31,004
+1,655
| +6% | +$162K | 0.04% | 387 |
|
|
2015
Q3 | $2.68M | Buy |
29,349
+1,327
| +5% | +$133K | 0.04% | 396 |
|
|
2015
Q2 | $2.97M | Sell |
28,022
-4,723
| -14% | -$523K | 0.04% | 389 |
|
|
2015
Q1 | $3.74M | Sell |
32,745
-2,924
| -8% | -$334K | 0.04% | 376 |
|
|
2014
Q4 | $3.93M | Buy |
35,669
+5,755
| +19% | +$607K | 0.05% | 376 |
|
|
2014
Q3 | $2.92M | Sell |
29,914
-2,927
| -9% | -$288K | 0.04% | 512 |
|
|
2014
Q2 | $3.31M | Sell |
32,841
-3,021
| -8% | -$295K | 0.04% | 458 |
|
|
2014
Q1 | $3.29M | Buy |
35,862
+2,457
| +7% | +$226K | 0.04% | 450 |
|
|
2013
Q4 | $3.02M | Buy |
33,405
+16,494
| +98% | +$1.43M | 0.05% | 523 |
|
|
2013
Q3 | $1.35M | Sell |
16,911
-11,513
| -41% | -$906K | 0.03% | 645 |
|
|
2013
Q2 | $2.07M | Buy |
+28,424
| New | +$2.13M | 0.04% | 445 |
|
Other funds holding ZBH
ProShare Advisors's ZBH Position: Q2 2026 in Review
ProShare Advisors increased its Zimmer Biomet (ZBH) stake by 21% in Q2 2026, buying an estimated $564K and bringing the position to 37,088 shares worth $3.19M. The position accounts for ﹤0.01% of the portfolio, ranked #632.
ProShare Advisors first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.93M in Q3 2024. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- ProShare Advisors held 37,088 shares of Zimmer Biomet worth $3.19M as of Q2 2026.
- ProShare Advisors bought 6,437 Zimmer Biomet shares in Q2 2026, an estimated $564K.
- Zimmer Biomet made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #632 holding.
- ProShare Advisors first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
- ProShare Advisors's Zimmer Biomet position peaked at $5.93M in Q3 2024.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.